2016
DOI: 10.1016/s0168-8278(16)01069-2
|View full text |Cite
|
Sign up to set email alerts
|

Next-Generation Proteasome Inhibitor Oprozomib Synergizes with Modulators of the Unfolded Protein Response to Suppress Hepatocellular Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
(34 reference statements)
0
1
0
Order By: Relevance
“…Therefore, while ER stress is necessary for the cancer progression and spread, the utility of ER stress inhibitors as anti-cancer drugs in the clinics will require careful consideration and critical evaluation of benefits and drawbacks. One possibility for treatment would be to combine UPR inhibitors with those targeting the proteasome as shown recently in case of models of hepatocellular carcinoma (Vandewynckel et al, 2016). …”
Section: Upr and Er Stress In Cancermentioning
confidence: 99%
“…Therefore, while ER stress is necessary for the cancer progression and spread, the utility of ER stress inhibitors as anti-cancer drugs in the clinics will require careful consideration and critical evaluation of benefits and drawbacks. One possibility for treatment would be to combine UPR inhibitors with those targeting the proteasome as shown recently in case of models of hepatocellular carcinoma (Vandewynckel et al, 2016). …”
Section: Upr and Er Stress In Cancermentioning
confidence: 99%